Russell Investments Group
CGON icon

Russell Investments Group’s CG Oncology CGON Stock Holding History

Russell Investments Group’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.9M Buy
167,429
+4,257
+3% +$278K 0.01% 972
2026
Q1 		$11M Buy
163,172
+19,826
+14% +$1.12M 0.01% 877
2025
Q4 		$5.95M Buy
143,346
+137,227
+2,243% +$5.68M 0.01% 1207
2025
Q3 		$246K Buy
6,119
+5,641
+1,180% +$164K ﹤0.01% 2733
2025
Q2 		$12.4K Buy
478
+13
+3% +$313 ﹤0.01% 3288
2025
Q1 		$11.4K Buy
465
+393
+546% +$11.1K ﹤0.01% 3215
2024
Q4 		$2.06K Sell
72
-15
-17% -$513 ﹤0.01% 3438
2024
Q3 		$3.28K Sell
87
-678
-89% -$23.8K ﹤0.01% 3297
2024
Q2 		$24.2K Buy
+765
New +$26.5K ﹤0.01% 2906

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Russell Investments Group's CGON Position: Q2 2026 in Review

Russell Investments Group increased its CG Oncology (CGON) stake by 2.6% in Q2 2026, buying an estimated $278K and bringing the position to 167,429 shares worth $11.9M. The position accounts for 0.01% of the portfolio, ranked #972.

Russell Investments Group first reported a position in CGON in Q2 2024 and has held it in 9 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Russell Investments Group held 167,429 shares of CG Oncology worth $11.9M as of Q2 2026.
  • Russell Investments Group bought 4,257 CG Oncology shares in Q2 2026, an estimated $278K.
  • CG Oncology made up 0.01% of Russell Investments Group's portfolio in Q2 2026, its #972 holding.
  • Russell Investments Group first reported a position in CG Oncology in Q2 2024 and has held it in 9 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.